[From molecule to medicine--drug development].
Bruhn
Claudia
C
D016907:Adverse Drug Reaction Reporting Systems / Q000191:economics; D000818:Animals; D002626:Chemistry, Pharmaceutical / Q000191:economics* / Q000379:methods*; D002986:Clinical Trials as Topic / Q000191:economics / Q000331:legislation & jurisprudence / Q000379:methods; D003431:Cross-Cultural Comparison; D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence / Q000379:methods; D004339:Drug Compounding / Q000191:economics* / Q000379:methods*; D004353:Drug Evaluation, Preclinical / Q000191:economics / Q000379:methods; D015507:Drugs, Investigational / Q000008:administration & dosage / Q000009:adverse effects / Q000138:chemical synthesis* / Q000493:pharmacokinetics; D005060:Europe; D006801:Humans; D040541:Marketing / Q000191:economics / Q000379:methods; D011358:Product Surveillance, Postmarketing; D014481:United States
D015507:Drugs, Investigational